STOCKHOLDERS’ EQUITY

3 Months Ended

Mar. 31, 2026

Equity [Abstract]

STOCKHOLDERS’ EQUITY

NOTE 3 – STOCKHOLDERS’ EQUITY

In the first quarter of 2026, we sold 6,000 shares of our common stock for $120,000 in private transactions. We did not pay commissions or finder’s fees and are using proceeds for working capital.

In the first quarter of 2025, we sold 503,750 shares of our common stock for $10,075,000 in private transactions. We did not pay commissions or finder’s fees and are using the proceeds for working capital.

In the first quarter of 2025, we issued 45,169 shares of our common stock to unrelated third parties as compensation for their consulting services. The stock was valued at $903,380.

As of March 31, 2026, the Company had 27,579,752 shares of common stock issued and outstanding.

The following table represents option activity for the three months ended March 31, 2026:

	Number of Options		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding – December 31, 2025		2,011,024	$	12.45		3.34	$	15,178,592
Exercisable – December 31, 2025		1,679,224	$	12.38		2.92	$	12,788,592
Granted		-	$	-
Forfeited		200,000	$	-
Vested		-
Outstanding – March 31, 2026		1,811,024	$	13.05		3.45	$	12,578,592
Exercisable - March 31, 2026		1,479,224	$	13.11		3.05	$	10,188,592

During the first quarter of 2026 we recorded $199,851 in stock option expenses compared to $460,019 in the first quarter of 2025.